SynthesisPharmacoEconomics - open2026

Cost-Effectiveness of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Blood Cancers: An Updated Systematic Review.

Nishma Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.